Dr. Myrlene Staten : NIDDK

Dr. Myrlene Staten

NIDDK, National Institutes of Health
Building 2DEM, Room 6107
6707 Democracy Blvd.
Bethesda, MD 20892
Tel: 301-402-7886
Fax: 301-480-3503
Email: statenm@mail.nih.gov

Current Position:
Senior Advisor, Diabetes Translational Research

Current Portfolio/Responsibilities:

Manage a portfolio of clinical translation and clinical treatment grants for type 2 diabetes. 
Run the Type 1 Diabetes – Rapid Access to Intervention Development preclinical drug development program. 

Program official for the TINSAL-T2D study, an efficacy study of salsalate in

      type 2 diabetes. 

Participate in other large, NIDDK clinical studies including HEALTHY and Longitudinal

      Assessment of Bariatric Surgery. 

Lead the Clinical Team within DEM

Previous Training and Experience:

B.S. in Nutrition, Summa Cum Laude, Texas Christian University, Fort Worth, TX


M.D., Graduation with High Honors, University of Texas Medical Branch,

      Galveston, TX (1976‑1979)

Internship and Residency in Medicine, University of California at Irvine Medical Center,

      Orange, CA (1979-1982)

Fellowship in Endocrinology and Metabolism, Washington University School

      of Medicine, St. Louis, MO (1982-1985)

Instructor, Assistant Professor, Department of Internal Medicine, Washington University

      School of Medicine (1985-1989)

Various clinical research positions with major pharmaceutical companies (1989-1999)

      including Amgen, Bristol-Myers Squibb and Hoffman-LaRoche

Vice President-CV/Endocrine/Metabolic Diseases Clinical Research, Pharmacia,

      Peapack, NJ (1999-2003)

Board certified in Internal Medicine and Endocrinology and Metabolism

Committees/ Working Groups:

NIDDK Bench to Bedside Translation Working Group (Chair)

The Biomarkers Consortium for the Foundation for the National Institutes of Health


NIDDK representative the NIH pilot RAID program (lead a subcommittee on IC

      Coordination and Outreach and participate in the NIH-RAID Evaluation and Planning


Type 2 diabetes planning group (Chair)

NIDDK Obesity Working Group

NIDDK Diabetes Complications Working Group

ADA Insulin Standardization Working Group

Page last updated: September 01, 2007

General inquiries may be addressed to: Office of Communications & Public Liaison
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services   USA.gov is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation